DNA databank marries bio samples and EMRs

Use of DNA variations as an indicator of patient response to medicines is one study underway that taps the newly available Vanderbilt University DNA databank, BioVU. The databank--currently available only to Vanderbilt researchers and collaborators--contains de-identified biological samples from 75,000 individuals collected since 2007 and has linked them the matching electronic medical records. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.